GlobalData on MSN22h
Dyno and Roche collaborate on neurological gene therapies
Dyno founder and CEO Eric Kelsic stated: “This new collaboration with Roche, focused on developing next-generation gene ...
Future Market Insights20h
Insect Cell Lines Market Set to Reach USD 3 Billion by 2033, Growing at a CAGR of 11.6%
Product launches is the main strategy followed by the manufacturers for insect cell lines market. On March 2020, Lonza has ...
Optimistic Buy Rating for BridgeBio Pharma’s BBP-812: Promising Phase 1/2 Results in Canavan Disease Therapy
Mizuho Securities analyst Salim Syed has maintained their bullish stance on BBIO stock, giving a Buy rating today. Salim Syed’s rating ...
BridgeBio Pharma’s BBP-812 Trial Shows Promise for Canavan Disease Amidst Focus on Acoramidis
Leerink Partners analyst Mani Foroohar has maintained their bullish stance on BBIO stock, giving a Buy rating today. Mani Foroohar’s ...
Ocuphire Pharma, Inc. Announces Acquisition of Opus Genetics
Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate sa ...